List view / Grid view
8 August 2016 | By Instituto Gulbenkian de Ciência
Researchers from the Instituto Gulbenkian de Ciência, Portugal, have discovered that the key controller of trunk, tail and spinal development is the Oct4 gene, one of the essential regulators of stem cells. The team intend to use their data to open new avenues to the study of spinal cord regeneration...
5 August 2016 | By MDI Biological Laboratory
The ability of animals to regenerate body parts has always fascinated scientists but until the advent of sophisticated tools for genetic and computational analysis, they had no way of studying the genetic machinery that enables regeneration...
4 August 2016 | By Bio-Rad Laboratories
The Bio-Plex System offers high-performance readers, industry-leading software, and sensitive assays in ready-to-use or custom configurations, enabling you to obtain high-quality data from limited samples...
4 August 2016 | By Bio-Rad Laboratories
The Bio-Rad automated S3e™ Cell Sorter allows you to perform simple 1–4 colour sorts in less than 30 minutes and greatly enhances your experimental success...
4 August 2016 | By Tokyo Institute of Technology
Certain species of amphibians and fish have the remarkable ability to regenerate tissue. Advances in molecular biological analyses have allowed researchers to identify specific molecules and signalling mechanisms involved in tissue regeneration. Fgf signalling is one such key mechanism...
3 August 2016 | By Plasticell
Plasticell has signed a collaboration agreement with the National University of Ireland, Galway (NUI Galway) focused on methods of eradicating cancer stem cells...
28 July 2016 | By IntelliCyt Corporation
Robust mix and read kits for cell- and bead-based screening applications...
25 July 2016 | By Niamh Louise Marriott, Digital Content Producer
Scientists have identified three types of vaccine-induced antibodies that can neutralise diverse strains of the flu virus that infect so many each year...
25 July 2016 | By Niamh Louise Marriott, Digital Content Producer
AbbVie and Bristol-Myers Squibb Company today announced a clinical trial collaboration to evaluate the safety, tolerability and efficacy of AbbVie’s investigational biomarker-specific antibody drug conjugate Rova-T...
22 July 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers have developed compounds that may prevent the development of epilepsy. In a new study, scientists found that these compounds prevented seizures and their damaging effects...
22 July 2016 | By Niamh Louise Marriott, Digital Content Producer
ReNeuron Group plc, a UK-based stem cell research company, today revealed further key pre-clinical efficacy data with its human retinal progenitor cells...
21 July 2016 | By Niamh Louise Marriott, Digital Content Producer
Antibiotic treatment decreases levels of disease-causing plaques, a hallmark of Alzheimer's disease, according to a new study by neuroscientists...
20 July 2016 | By Niamh Louise Marriott, Digital Content Producer
Scientists discovered an interaction in neurons that contributes to Parkinson's disease, showing how drugs now under development could block the process...
19 July 2016 | By Niamh Louise Marriott
A*STAR and MSD have formed a two year collaboration aimed at improving cellular delivery of macrocyclic peptides...
12 July 2016 | By Victoria White, Digital Content Producer
Sorrento and Servier are teaming up to develop, manufacture and commercialise products using Sorrento's monoclonal antibody, STI-A1110...
